UK markets open in 3 hours 18 minutes

Sarepta Therapeutics, Inc. (SRPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
127.39+3.14 (+2.53%)
At close: 04:00PM EDT
125.01 -2.38 (-1.87%)
After hours: 07:06PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close124.25
Open123.00
Bid127.11 x 200
Ask127.46 x 200
Day's range121.91 - 130.61
52-week range55.25 - 159.89
Volume1,486,719
Avg. volume838,243
Market cap11.956B
Beta (5Y monthly)0.95
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Business Wire

    Sarepta Therapeutics to Announce First Quarter 2024 Financial Results

    CAMBRIDGE, Mass., April 24, 2024--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report first quarter 2024 financial results after the Nasdaq Global Market closes on Wednesday, May 1, 2024. Subsequently, at 4:30 p.m. E.T., the Company will host a conference call to discuss its first quarter 2024 financial results.

  • Business Wire

    Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    CAMBRIDGE, Mass., March 29, 2024--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on March 29, 2024 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2024 Employment Commencement Incentive Plan, as a material inducement to employment to 8 individuals hired by Sarepta in March 2024. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).

  • Business Wire

    Sarepta Therapeutics to Present at Upcoming Investor Conferences

    CAMBRIDGE, Mass., March 04, 2024--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in fireside chats at two upcoming investor conferences: